Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol for Sub-Study of the ASCOT Trial
  • Published:

Protocol for Sub-study of the ASCOT Trial

Non-specific effects of inclusion in a clinical trial: information from ASCOT

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Karjalainen S, Palva I Do treatment protocols improve end results? A study of survival ofpatients with multiple myeloma in Finland BMJ 1989 299 1069–1072

    Article  CAS  Google Scholar 

  2. The social problems of an industrial civilisation Chapter IV; ‘Hawthorne and the Western Electric Company’ Elton Mayo: Routledge (London) 1949

    Google Scholar 

  3. Sandler AD et alLack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder NEJM 1999 341 1801–1806

    Article  CAS  Google Scholar 

  4. Shapiro AK, Shapiro E The powerful placebo: from ancient priest to modern physician Johns Hopkins University Press: Baltimore 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

Corresponding author

Correspondence to S Thom.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thom, S., Whitehouse, A., Sever, P. et al. Non-specific effects of inclusion in a clinical trial: information from ASCOT. J Hum Hypertens 15 (Suppl 1), S81–S82 (2001). https://doi.org/10.1038/sj.jhh.1001092

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001092

Keywords

Search

Quick links